https://www.proactiveinvestors.com.au/companies/news/1094215/recce-pharmaceuticals-gains-key-approval-to-advance-diabetic-foot-infection-trial-to-pivotal-phase-3-1094215.html

This is an ingested summary. Full reporting is available at the primary source below.